Healthpeak Properties, Inc. (NYSE:DOC) Shares Bought by Mirador Capital Partners LP

Mirador Capital Partners LP lifted its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 2.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,132 shares of the real estate investment trust’s stock after buying an additional 901 shares during the quarter. Mirador Capital Partners LP’s holdings in Healthpeak Properties were worth $672,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. State Street Corp acquired a new stake in shares of Healthpeak Properties in the third quarter worth approximately $1,093,576,000. Geode Capital Management LLC acquired a new stake in Healthpeak Properties in the 3rd quarter valued at approximately $403,898,000. Charles Schwab Investment Management Inc. acquired a new position in Healthpeak Properties during the third quarter worth $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. purchased a new position in Healthpeak Properties during the 3rd quarter valued at about $102,615,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Shares of DOC stock opened at $20.44 on Thursday. The company’s fifty day simple moving average is $20.98 and its 200-day simple moving average is $21.48. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. Healthpeak Properties, Inc. has a 52 week low of $16.01 and a 52 week high of $23.26. The company has a market cap of $14.30 billion, a PE ratio of 43.49, a P/E/G ratio of 2.12 and a beta of 1.14.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.32). Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The company had revenue of $700.40 million for the quarter, compared to analysts’ expectations of $682.51 million. During the same quarter in the previous year, the business posted $0.45 earnings per share. The business’s quarterly revenue was up 25.9% compared to the same quarter last year. As a group, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.81 EPS for the current year.

Healthpeak Properties Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were paid a dividend of $0.30 per share. The ex-dividend date was Monday, November 4th. This represents a $1.20 annualized dividend and a dividend yield of 5.87%. Healthpeak Properties’s dividend payout ratio is presently 255.32%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DOC. Royal Bank of Canada boosted their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price objective for the stock from $20.00 to $28.00 in a report on Monday, October 21st. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a report on Wednesday. StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Finally, Robert W. Baird upped their target price on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $24.15.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.